Aims and Scope
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research.
|Publication Model||Subscription; with hybrid open access option|
|Indexed by||Science Citation Index, Index Medicus (Medline), Excerpta Medica (Embase), BIOSIS Previews, Sociedad Iberoamericana de Informacion Cientifica (SIIC)|
|Impact Factor||12.350 (2017)|
|CiteScore||8.31, rank 1/53 (2017)|
|Peer Review Model||Single blind; the names of reviewers are hidden from the author|
|Acceptance Rate||12% for original research submitted in 2016|
|Time from submission to first decision||17 days|
|Time from acceptance to online publication||13 days|
Rights and Permissions
ARD is the official journal of EULAR – the European League Against Rheumatism and all (scientific) delegates to the annual EULAR congress receive a complimentary 12 month subscription to the journal.
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.